Chinook: Q4 Earnings Snapshot

SEATTLE (AP) — SEATTLE (AP) — Chinook Therapeutics, Inc. (KDNY) on Monday reported a fourth-quarter loss of $62.6 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Seattle-based company said it had a loss of 90 cents.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 79 cents per share.

The drug developer posted revenue of $512,000 in the period.

For the year, the company reported that its loss widened to $187.9 million, or $2.92 per share. Revenue was reported as $6.1 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on KDNY at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up